Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For $AMRN, it's more GARBAGE2RUBBISH
I really want to believe it. But the sales number keep telling me that's not the case. See the latest tweet from raf.
#Vascepa scripts @Amarincorp $AMRN pic.twitter.com/PGZfDmAC2b
— Raf (@ra_fun) August 20, 2021
Going to be back to $4 ish.
Stagnant script sales. The market doesn't see much future for this company with its current strategy. BOD and Management also kept fattening their asses with generous stock rewards (our money), no incentive for them to sell their golden goose.
But the number has been stagnant. There was even someone who reported VASCEPA was out of stocks a couple of weeks ago.
Stagnant VASCEPA script sales, could $AMRN also be affected by lack of raw material?
Probably by next week.
with this rate, $AMRN will achieve it by end of the week. Pathethic...
Thanks for sharing the technical analysis. It's just sad a great drug is being mismanaged by an incompetent company like this. Imagine how many lives could be potentially saved from CVD if VASCEPA were handled better?
Nope. May never be.
What would this godforsaken company be?
He needs to milk $AMRN more and more to further fatten his a**
Price tanked 9%. Totally agree with this fact
Expected outcome for $AMRN. Set backs after set backs.
Unfortunately, no such intervention happened to $AMRN for the last 2 years.
Do you have a link to it?
That's a sad thing... One incompetent and corrupt judge demolished a company, destroyed someone's (or many people's) retirement plan, and prevented the introduction of an amazing drug to the masses (assuming $AMRN would have more capital to do GIA).
Indeed.. Show us sales result..... It has been very bad...
As everything regarding $AMRN, expect nothing will drastically change. The new CEO should demonstrate sales...
Hi Sleven,
I know it's important. But $AMRN has failed me numerous times for any kind of this hearing....
Usually it's a nothing burger for $AMRN... They need to show the sales...
We are returning back to $4 sooner than predicted. So pathetic.
Downgrade start to come. What a shitty stock.
Thanks for the reply, seems that I should reposition my stake in $AMRN
Or am I being delusional thinking something is always around the corner??? Stupid Du destroyed this company.
delayed indefinitely? :(
Exactly, the price is steadily dropping back to $4. Unbelievable. It's faster than I expected and yet no word from them.
Exactly, I still can't understand that why $AMRN never mentioned its product VASCEPA in their tweet?
I'm still invested though. Hopefully, with solid science backed with the strong clinical trial result, the new CEO can pull the nose of this plane up to prevent it from stalling and crashing down.
$AMRN investors are the most optimistic people in the whole universe... I would like our wishes to come true, but this company has failed me over and over.
It's first week of May, and the price is already dropping to $4.78, flirting to $4.6 "resistance"... I think it might go even lower by end May :(
Steady decline to $4. Possibly even lower to $2.9 as predicted in the next 3 months. LOL.
LOL. Basically another nothing burger.
Maybe this is why we are seeing the stock slowly sinking back to $4.
They blamed COVID and natural disaster over and over again... Only those who can't execute have 1001 excuses.
This is from Biostock tweet. Fall short from your prediction. Seems like declining Q1. My god I’m so frustrated.
$AMRN Q1 net revenue $142.2M
— Bio Stocks™ (@BioStocks) April 29, 2021
$538.7M in cash & investments.
Generic version of VASCEPA launched in Nov'20 has captured ~ 9% of the total icosapent ethyl prescriptions in Q1.
Other generic versions of VASCEPA also have approval to launch in U.S, they have not yet done so.
I wonder, why Amarin never mentioned their drug name "VASCEPA" in their Twitter post? $AMRN
Congrats everyone. We are back to sub-$5 and dropping.
What’s the floor right now? Back to $4 again?
I think it’ll settle -10% today, another 5% tomorrow before it finds its direction.
BO or M&A not happening anytime soon.